BIO Protocol: A New Era of Decentralized Scientific Research and Commercialization

BIO Protocol is a decentralized science (DeSci) platform that aims to promote the funding, development and sharing of intellectual property (IP) for biotechnology research through a decentralized autonomous organization (DAO) model. Its goal is to address the uneven distribution of funds in traditional biomedical research and encourage research on rare diseases, longevity research and other emerging health challenges.

BIO Protocol is a decentralized science (DeSci) platform that aims to promote the funding, development and sharing of intellectual property (IP) for biotechnology research through a decentralized autonomous organization (DAO) model. Its goal is to address the uneven distribution of funds in traditional biomedical research and encourage research on rare diseases, longevity research and other emerging health challenges.

BIO Protocol’s origins can be traced back to its team’s work at early biomedical tokenization platform Molecule and longevity science community VitaDAO, while BIO Protocol was officially launched as an independent project in 2024.

The project team has begun to build the De-Sci ecosystem, using the successful experience accumulated in Molecule and VitaDAO as the cornerstone to start pioneering exploration. They deeply analyze the pain points of traditional scientific research and combine cutting-edge blockchain technology to lay a solid foundation for subsequent development.

In late 2024, BIO Protocol was officially established and began to build the BioDAOs network to attract the participation of scientists, patients and investors and promote research projects in multiple scientific fields.

Binance Labs made its first De-Sci investment in BIO Protocol, providing important financial support and industry recognition for the project's development.

BIO Protocol completed the issuance of BIO Genesis tokens, raising more than $33 million. At the same time, the BIO token airdrop plan was launched to attract early supporters and active community members from around the world to participate deeply, laying the foundation for the rapid expansion of the project ecosystem and stimulating community vitality.

In January 2025, the BIO token will be launched on Binance Launchpool and is planned to be launched on Ethereum, Solana and Base networks, expanding the token circulation channels in all directions, enhancing the project's influence and market coverage, and building a diversified bridge for subsequent capital flow and value exchange within the ecosystem.

The core team of BIO Protocol is composed of senior experts in the fields of blockchain and biotechnology, including:

Paul Kohlhaas, who holds multiple positions, is the co-founder of BIO Protocol, the founder and CEO of Molecule, and the co-founder of VitaDAO. He has profound attainments in the integration of blockchain and biotechnology. He previously worked for ConsenSys and the Swiss government blockchain project.

Clemens Ortlepp, co-founder and chief product officer (CPO) of BIO Protocol, founder of MTX Studio, focuses on decentralized technology innovation. He leads the creation of BIO Protocol user-end products to ensure that the platform has a friendly interactive interface and efficient operation process.

James Sinka focuses on R&D and community sectors. On the one hand, he has deep roots in blockchain technology research and development to ensure the stability, efficiency, and continuous iterative optimization of the underlying technical architecture of BIO Protocol; on the other hand, he is good at community operations, gathering the strength of patients, scientists, enthusiasts and other groups scattered around the world to create an active and creative community ecology.

Jose Pinto, legal counsel, is familiar with laws and regulations in many parts of the world, especially in the field of cryptocurrency. He escorts projects on the thorny road of compliance operation and response to regulatory challenges, from the establishment of business structure and compliance review of token issuance in the early stage of project launch to contract drafting and intellectual property protection in daily operations, providing professional legal support in every detail to ensure that projects move forward steadily in a complex and changing legal environment and avoid development being hindered by legal risks.

Leonard Boltz, product expert, is responsible for carving out every detail that users come into contact with, breaking down the grand vision of BIO Protocol into practical and convenient tools. He is committed to creating the ultimate user experience, allowing users with different knowledge levels and technical backgrounds to easily get started, seamlessly integrate into the ecosystem, and promote the large-scale popularization of the project.

Nate Hindman, Head of Growth, keeps a close eye on market dynamics, user needs and industry trends. He is committed to expanding the influence of BIO Protocol and attracting more scientists, patients and cryptocurrency community members to join by formulating precise marketing strategies, expanding cooperation channels, and holding online and offline events.

BIO Protocol is the financial layer of decentralized science (DeSci), designed to accelerate the flow of capital and talent into on-chain science. The protocol aims to catalyze the on-chain economy of scientific communities (BioDAOs) and create a deep, liquid, and efficient market for scientific IP developed by BioDAOs.

BIO Protocol has five core functions:

( 1 ) Curation ( BIO Staking )

BIO token holders join the ecosystem by participating in screening new BioDAOs, using a bottom-up approach to fund scientific research. Community-selected BioDAOs will be funded, added to the treasury, and supported by the BIO Protocol. Because the BIO Protocol relies on high-quality BioDAOs, Curation requires locked BIO (